Frequency of diabetes, impaired fasting glucose, and glucose intolerance in high-risk groups identified by a FINDRISC survey in Puebla city, Mexico

Diabetes, Metabolic Syndrome and Obesity

Volumn 5, Issue , 2012, Pages 403-406

  García Alcalá, Hector ^a   Nathalie, Christelle ^a   Genestier Tamborero, ^a   Hirales Tamez, Omara ^a   Salinas Palma, Jorge ^a   Soto Vega, Elena ^a  

^a UNIVERSIDAD POPULAR AUTÓNOMA DEL ESTADO DE PUEBLA   (Mexico)

Author keywords

Diabetes prevention; Diabetes Puebla; Diabetes risk; Diabetes survey; FINDRISC Mexico

Indexed keywords

GLUCOSE;

AGE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISORDERS OF CARBOHYDRATE METABOLISM; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HEALTH SURVEY; HIGH RISK PATIENT; HUMAN; IMPAIRED FASTING GLUCOSE; MAJOR CLINICAL STUDY; MALE; MEXICO; MORBIDITY; ORAL GLUCOSE TOLERANCE TEST; PATIENT CODING; POPULATION RESEARCH; REFERENCE VALUE; RISK ASSESSMENT; SCORING SYSTEM; SEX DIFFERENCE; URBAN AREA; URBAN POPULATION;

EID: 84872354573     PISSN: 11787007     EISSN: None     Source Type: Journal    
DOI: 10.2147/DMSO.S35545     Document Type: Article

References (9)

1. Villalpando S, de la Cruz V, Rojas R, et al. Prevalence and distribution of type 2 diabetes mellitus in Mexican adult population: a probabilistic survey. Salud Pública Mex. 2010;52 Suppl 1:S19-S26. Spanish.
2. Burguete-Cabañas T, Zacarías-Castillo R, Mata-Miranda P. Diabetes mellitus mortality. Eleven years experience at a second level hospital. Salud Pública Mex. 2006;48:445. Spanish.
3. Hernandez-Romieu AC, Elnecavé-Olaiz A, Huerta-Uribe N, et al. Analysis of population survey for determining the factors associated with the control of diabetes mellitus in Mexico. Salud Pública Mex. 2011;53:34-39. Spanish.
4. Holman RR, Paul SK, Bethel MA, et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359: 1577-1589.
5. Tuomiletho J, Lindström J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1345-1350.
6. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393-403.
7. Makrilakis K, Liatis S, Grammatikou S, et al. Validation of the Finnish diabetes risk score (FINDRISC) questionnaire for screening for undiagnosed type 2 diabetes, dysglycaemia and the metabolic syndrome in Greece. Diabetes Metab. 2011;37:144-151.
8. Schwarz P, Li J, Reimann M, et al. The Finnish diabetes risk score is associated with insulin resistance and progression towards type 2 diabetes. J Clin Endocrinol Metab. 2009;94:920-926.
9. Brodovicz K, Dekker J, Rijkelijkhuizen J, et al. The Finnish diabetes risk score is associated with insulin resistance but not reduced b-cell function, by classical and model-based estimates. Diabet Med. 2011;28:1078-1081.